Figure 1 Evolution of multiple sclerosis

Slides:



Advertisements
Similar presentations
Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Advertisements

Four Known Types of MS Clinically isolated syndrome (CIS)
Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Life expectancy at birth in all countries included
MRI and possible differentiating features with nonconventional MRI
Figure 1 Perivenous distribution of multiple sclerosis lesions
Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Overview of risk factors for Parkinson disease dementia
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for
Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Co-stimulatory receptors as immunomodulatory targets
Figure 1 Diagnostic tiers of Parkinson disease as single disease
Figure 3 Archetypal MS clinical course depicted over 20 years
Discussion and Concluding Remarks
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Allele frequency and effect size for ALS-associated genes
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Hypothetical mechanisms of smoking-associated
Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Environmental factors contributing to IBD pathogenesis
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Clinical correlates of neurodegeneration in MS
Figure 3 Genetic pleiotropy in ALS
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Lifestyle and environmental factors affect
Figure 1 The trajectory of cognitive ageing
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Stroke-related deaths and DALYs by country development status
Figure 2 Age-specific prevalence of common comorbidities
Figure 4 11C-PK11195-PET scans showing the evolution of neuroinflammation in a patient after stroke Figure 4 | 11C-PK11195-PET scans showing the evolution.
Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET
Figure 6 Combining population-wide and high-risk strategies
Nat. Rev. Urol. doi: /nrurol
Figure 1 Biomarkers associated with different clinical phases in MS
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Potential interplay between physiological
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 The current model of the pathogenesis of SLE
Figure 1 Clinical aspects of LGMD subtypes
Figure 1 The VEGF family of growth factors
Figure 1 Timing of the effects of deep brain stimulation
Figure 5 Interaction between infarction and amyloid deposition
Figure 1 A large number of genes are potentially associated with CIPN
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Rett syndrome severity and age at diagnosis by mutation type
Nat. Rev. Neurol. doi: /nrneurol
Figure 5 Pairwise correlations between selected patient-reported outcomes and performance tests in patients with MS (A) The number of pairwise correlations.
Nat. Rev. Neurol. doi: /nrneurol
Figure 7 VEGF as a mediator of neuroinflammatory disease
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Pedigrees of 3 multiplex families with NLRP3 mutations and MS The patient numbers refer to the patients listed in table 1. Pedigrees of 3 multiplex.
Figure Overview of patients with demyelinating diseases, presence of clinical symptoms frequently associated with NMDAR encephalitis, and antibody status.
Figure 4 Four representative disease-course archetypes
Figure 2 Network connections of the hypothalamus
Presentation transcript:

Figure 1 Evolution of multiple sclerosis Figure 1 | Evolution of multiple sclerosis. Several factors that predispose to multiple sclerosis (MS) are at play during the subclinical phase of the disease, before clinically recognizable symptoms are present. The light blue area represents progression of MS, and bars denote events that cause inflammatory damage to the CNS, some of which do not reach the clinical threshold. Arrows denote episodes of new inflammation in the CNS, recorded by MRI, and are much more frequent than clinical relapses. Olsson, T. et al. (2016) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.187